Sub-Total: $0.00
Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Complimentary
Related products
-
Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Read more -
Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
Read more -
Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation
Read more -
New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Read more
